Rheumatoid arthritis (RA) is associated with a higher rate of heart failure subtypes, according to a study published online ...

Rheumatoid arthritis (RA) is associated with a higher rate of heart failure subtypes, according to a study published o ...

Our top content from the 100th annual American Heart Association (AHA) Scientific Sessions included exclusive expert insights ...

The following is a summary of “Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity,” published in the ...

Industry-First Capabilities Combined: Medera’s Novoheart has a unique human-based mini-Heart technology platform for disease modelling and drug screening with a track record of supporting FDA IND and ...

Cibotercept is a fusion protein commercialized by Keros Therapeutics, with a leading Phase II program in Pulmonary Arterial Hypertension.

A new study published in the Frontiers in Cardiovascular Medicine journal showed that right ventricular (RV) dysfunction is ...

The rNPV model is a more conservative valuation measure that accounts for the risk of a drug in clinical development failing to progress. Volenrelaxin is under development for the treatment of chronic ...

Here are the highlights from the 2024 ESC Congress. You can check out more of our coverage and interviews from the meeting by ...

SGLT2 inhibitors plus finerenone may have a protective effect against cardiovascular events in patients with HFpEF or HFmrEF.

Innovation installed by AstraZeneca for advancing human heart-based R&D for investigational cardiovascular therapiesFeatures improved ...

Progress in assessing cardiovascular risk and identifying early prevention opportunities, improvements in treating heart failure, new therapies for bleeding strokes, strategies for reducing the ...